ABBV vs EBF · P/E 81, rev $61.16B vs P/E 12, rev $394.6M
AbbVie Inc (ABBV) versus Ennis Inc (EBF) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Ennis Inc (EBF) is a business equipment & supplies company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EBF revenue for 2025-02-28 was $394.6M. Net income was $40.2M. Revenue was down 6.1% from 2024-02-29 to 2025-02-28. EBF currently screens at market cap $473.9M and trailing P/E 12.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EBF currently screens at market cap $473.9M and trailing P/E 12.2.
Not investment advice. Open the ABBV and EBF stock pages for the full models.
Not investment advice.